EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

Umbilical cord tissue-derived mesenchymal stem cells for teatment of multiple sclerosis

The aim of this study is to assess the safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (UC-MSCs) administered to multiple sclerosis (MS) patients.

Translational Biosciences is a subsidiary of Medistem Panama Inc., founded solely to conduct clinical trials using adult stem cells and adult stem cell-derived products.
See additional Cell Therapies for: Brain , Spinal Cord
Umbilical cord tissue-derived mesenchymal stem cells for teatment of multiple sclerosis